Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

Surgical Oncology, Recist Guideline, Medicine +9

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.2K citations · Full text

Surgical Oncology, Chemotherapy Versus Chemotherapy, Gastrointestinal Oncology +8

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

David Cunningham, Naureen Starling, Sheela Rao et al. · New England Journal of Medicine · 2008 · 2.3K citations

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

Manfred Hofmann, Di Shi, Reinhard Büttner et al. · Histopathology · 2008 · 1.2K citations

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012

Kyu‐Won Jung, Young‐Joo Won, Hyun-Joo Kong et al. · Cancer Research and Treatment · 2015 · 1.2K citations · Full text